What is COGT's dilution risk score?

COGT has a latest available DilutionScore record of 36/100, categorized as medium dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for COGT, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for COGT?

DilutionWatch tracks 25 SEC filing types for COGT including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect COGT shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For COGT, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for COGT tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for COGT. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

COGT Dilution Risk Score: 36/100 (MEDIUM)

Score Breakdown

📋 Offering Ability

32

💰 Cash Runway

65

📊 Float Risk

7

⚠️ Warrant Exposure

15

🔄 Convertible Debt

15

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 7%

💰 Capital Raise model 15%

• Under 12 months cash (9mo)

🔔 Track COGT — Get forecast alerts →

Market Data

Market Cap$5.97B

Shares Outstanding173.52M

Float160.86M

Cash$187.87M

Debt$44.25M

Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

Field	Current Value	Basis
DilutionScore	36/100	DilutionWatch score record
Shares Outstanding	173.52M	Verified float table or market cache
Public Float	160.86M	Verified float table or market cache
Market Cap	$5.97B	Market data cache
Cash Runway	9.2 months	DilutionWatch score inputs
Shelf Capacity	None in current score inputs	SEC-derived dilution fields
ATM Capacity	None in current score inputs	SEC-derived dilution fields
Outstanding Warrants	3.03M	SEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 18.2% shares (2026Q1 vs prior)

309 institutional holders · 209.90M shares

#1 FMR LLC 23.12M shares

#2 BlackRock, Inc. 16.05M shares

#3 VANGUARD CAPITAL MANAGEMENT LLC 13.79M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest18.75M

Days to Cover12.1

% of Float11.7%

FINRA data as of Aug 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31

xbrl XBRL CONVERTIBLE 2018-12-31

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual COGT Dilution Snapshot

Cogent Biosciences, Inc. (COGT) has a DilutionScore of 36/100, rated Medium dilution risk. Score date: September 12, 2026.

Stored outstanding warrants: 3.0M.
Recent SEC activity tracked for COGT: xbrl on 2025-12-31; xbrl on 2018-12-31.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.